echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Counterfeit HIV drug ravages DOJ probe into Gilead, GSK, J&J-related drugs

    Counterfeit HIV drug ravages DOJ probe into Gilead, GSK, J&J-related drugs

    • Last Update: 2022-04-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    Recently, as counterfeit drugs against AIDS (HIV) drugs such as Biktarvy, Descovy and Symtuza are rampant, the US Department of Justice has launched an investigation into counterfeit drugs from Gilead, GlaxoSmithKline and Johnson & Johnson, and strives to clear the circulation system of patients' health and treatment.
    Substandard drugs

    Biktarvy and Descovy are both anti-AIDS drugs under Gilead

    Among them, Biktarvy is an antiretroviral cocktail therapy for HIV/AIDS, consisting of three fixed-dose drugs, and in 2020, the sales of the drug reached 8.

    In July 2021, Gilead sued a drug distributor with 70 pharmacies, alleging they sold more than $250 million in counterfeit Biktarvy and Descovy drugs in the U.
    over the past two years, seriously endangering the health of patients

    The company issued a statement in August 2021 alerting consumers to the substandard and falsified Biktarvy and Descovy drugs that are on the rise in the United States

    It's not just Gilead that is troubled by counterfeit anti-AIDS drugs.
    Johnson & Johnson warned patients of counterfeit drugs for its anti-HIV drug Symtuza as early as the end of 2020

    During the pandemic, the sale of counterfeit medicines has increased due to disruptions in legitimate supply chains and limited regulatory enforcement

    Anti-HIV drugs are often provided by Medicare and Medicaid to patients in need at low or no cost, by manufacturers buying the drugs from homeless or drug-addicted AIDS patients and falsely resold to pharmacies

    Patients taking Biktarvy will cost $3,751 per month, while Johnson & Johnson's Symtuza costs even more at $4,490 per month

    In some cases, the resold drugs were from the original manufacturer but expired or were falsely resold

    In other cases, the drugs were over-the-counter pain relievers or antipsychotics rather than antivirals, and they were simply put in vials labeled Biktarvy or Descovy

    At present, the U.
    Department of Justice has intervened in the investigation and worked with related companies and the FDA to remove all counterfeit drugs

    Maryland-based wholesale distributor Safe Chain Solutions is one of the defendants in Gilead's lawsuit, but the company says it never knowingly sold counterfeit products

    Original source:


    https:// https://
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.